Back to search

Article

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumors

2022-06-26

Abstract excerpt

Emerging evidence supports FDX1’s important role in the development and progression of cancer, but no extensive cancer analysis is available to date. This study was the first to comprehensively explore the expression of FDX1 in 33 types of cancer and the significance of FDX1 in clinical prognosis by using bioinformatics techniques. Meanwhile, we analyzed the relationship between FDX1 and pathological stage, as wel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f5f0d24e-3657-5474-8880-d0c017370a9b
DOI
10.1101/2022.06.22.497145
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsDOI 10.1101/2022.06.22.497145
Select a neighboring publication to make it the new centre.